Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: F13K378W4L

Structure

InChI Key HSQAARMBHJCUOK-UHFFFAOYSA-N
Smile O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CCCNCCCO)ccc1Cl
InChI
InChI=1S/C24H35ClN2O2/c25-22-5-4-17(3-1-6-26-7-2-8-28)12-21(22)23(29)27-16-24-13-18-9-19(14-24)11-20(10-18)15-24/h4-5,12,18-20,26,28H,1-3,6-11,13-16H2,(H,27,29)

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H35ClN2O2
Molecular Weight 419.01
AlogP 4.19
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 10.0
Polar Surface Area 61.36
Molecular species BASE
Aromatic Rings 1.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST P2X purinoceptor 7 antagonist Other Other PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Ion channel Ligand-gated ion channel P2X receptor
- 10 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 2 D001172 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL3545108
DrugBank DB12594
FDA SRS F13K378W4L
Guide to Pharmacology 7826
SureChEMBL SCHEMBL4126642
ZINC ZINC000034356159